🇺🇸 FDA
Patent

US 8735082

Gene signature for predicting prognosis of patients with solid tumors

granted A61PA61P35/00

Quick answer

US patent 8735082 (Gene signature for predicting prognosis of patients with solid tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00